Clinical Use of Continuous Glucose Monitoring in Critically Ill Pediatric Patients with Diabetic Ketoacidosis
Diabetes Technology & Therapeutics · 2023
DOI: 10.1089/dia.2023.0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2023. Verfasst von Esther Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jeonbuk National University Children's Hospital, Jeonju, Korea. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Diabetes Mellitus. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The use of continuous glucose monitoring (CGM) in pediatric patients with diabetic ketoacidosis (DKA) remains investigational, and data on its accuracy in pediatric intensive care units (PICU) are limited. This study evaluated the accuracy of three CGM devices in pediatric patients with DKA in the PICU.
Methods
We compared 399 matched pairs of CGM and point-of-care capillary glucose (POC) values and grouped patients based on whether they changed their CGM sensor during their PICU stay.
Results
Eighteen patients with a mean age of 10.98 ± 4.20 years were included, with three patients in the sensor change group. The overall mean absolute relative difference (MARD) was 13.02%. The Medtronic Guardian Sensor 3 ( n = 331), Dexcom G6 ( n = 41), and Abbott FreeStyle Libre 1 ( n = 27) showed MARD values of 13.40%, 11.12%, and 11.33%, respectively. The surveillance error grid (SEG), Bland–Altman plot, and Pearson's correlation coefficient demonstrated satisfactory clinical accuracy of the CGM devices (SEG zones A and B, 98.5%; mean difference, 15.5 mg/dL; Pearson's correlation coefficient [ r 2 ], 0.76, P < 0.0001). MARD was significantly lower in subjects who did not experience a sensor change (11.74% vs. 17.31%, P = 0.048). Also, a statistically significant negative correlation was found between serum bicarbonate levels and POC–CGM values ( r = −0.34, P < 0.001).
Conclusions
The severity of DKA has a major effect on reducing the accuracy of the CGM, especially during the first several days in the intensive care unit. The reduced accuracy appears to be related to acidosis, as reflected in the serum bicarbonate levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Jeonbuk National University Children's Hospital, Jeonju, Korea.
- Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju-si, Korea.
- Department of Pediatrics, Jeonbuk National University Medical School, Jeonju-si, Korea.
ORCID-Profile: Esther Park
Zitieren
APA
Park, E., & Kim, M. (2023). Clinical Use of Continuous Glucose Monitoring in Critically Ill Pediatric Patients with Diabetic Ketoacidosis. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0012
Vancouver
Park E, Kim M. Clinical Use of Continuous Glucose Monitoring in Critically Ill Pediatric Patients with Diabetic Ketoacidosis. Diabetes Technology & Therapeutics. 2023. doi:10.1089/dia.2023.0012
BibTeX
@article{Park2023,
author = {Park, Esther and Kim, Minsun},
title = {Clinical Use of Continuous Glucose Monitoring in Critically Ill Pediatric Patients with Diabetic Ketoacidosis},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
doi = {10.1089/dia.2023.0012}
}
EUVIMED